(Q37242654)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

review article

1 reference

title

The antiviral activities of artemisinin and artesunate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Marta R. Romero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Jose J Marin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

4

Thomas Stamminger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Dana G Wolf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Manfred Marschall

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

1 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

804-811

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18699744%20AND%20SRC:MED&resulttype=core&format=json

WHO, the Global Fund, and medical malpractice in malaria treatment

12 January 2020

cites work

1 reference

Artesunate combinations for treatment of malaria: meta-analysis

21 January 2018

1 reference

Molecular modes of action of artesunate in tumor cell lines.

21 January 2018

1 reference

Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy.

21 January 2018

1 reference

Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells

21 January 2018

1 reference

Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside

21 January 2018

1 reference

Artemisinin: mechanisms of action, resistance and toxicity

21 January 2018

1 reference

Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies

21 January 2018

1 reference

Development of QSAR models to predict and interpret the biological activity of artemisinin analogues

21 January 2018

1 reference

A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR.

21 January 2018

1 reference

Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria.

21 January 2018

1 reference

Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria

21 January 2018

1 reference

A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria.

21 January 2018

1 reference

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives

21 January 2018

1 reference

Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria

21 January 2018

1 reference

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria

21 January 2018

1 reference

Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin

21 January 2018

1 reference

Effects of artemisinin, artemether, arteether on the pharmacokinetics of carbamazepine

21 January 2018

1 reference

Pharmacokinetic interactions of antimalarial agents

21 January 2018

1 reference

Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data

21 January 2018

1 reference

Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling

21 January 2018

1 reference

Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor.

21 January 2018

1 reference

In vivo and mechanistic evidence of nuclear receptor CAR induction by artemisinin.

21 January 2018

1 reference

Cytochrome P450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells

21 January 2018

1 reference

Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans

21 January 2018

1 reference

Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects

21 January 2018

1 reference

A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction

21 January 2018

1 reference

Are currently deployed artemisinins neurotoxic?

21 January 2018

1 reference

Neurotoxicity in animals due to arteether and artemether

21 January 2018

1 reference

Dose-dependent brainstem neuropathology following repeated arteether administration in rats.

21 January 2018

1 reference

Behavioral and neural toxicity of arteether in rats.

21 January 2018

1 reference

Toxic brainstem encephalopathy after artemisinin treatment for breast cancer

21 January 2018

1 reference

Arteether-induced brain injury in Macaca mulatta. I. The precerebellar nuclei: the lateral reticular nuclei, paramedian reticular nuclei, and perihypoglossal nuclei.

21 January 2018

1 reference

A trial of artemether or quinine in children with cerebral malaria

21 January 2018

1 reference

A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria

21 January 2018

1 reference

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

21 January 2018

1 reference

The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.

21 January 2018

1 reference

Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses.

21 January 2018

1 reference

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation

21 January 2018

1 reference

Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents

21 January 2018

1 reference

Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB.

21 January 2018

1 reference

Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling

21 January 2018

1 reference

Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer

21 January 2018

1 reference

NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?

21 January 2018

1 reference

Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes

21 January 2018

1 reference

RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response.

21 January 2018

1 reference

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts

21 January 2018

1 reference

A modified technique for the detection of hepatitis B virus-specific DNA polymerase

21 January 2018

1 reference

Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype

21 January 2018

1 reference

Natural history of hepatitis B and C virus infections

21 January 2018

1 reference

Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.

21 January 2018

1 reference

Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication

21 January 2018

1 reference

Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents

21 January 2018

1 reference

Antiviral actions of interferons

21 January 2018

1 reference

Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus

21 January 2018

1 reference

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

21 January 2018

1 reference

Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV).

21 January 2018

1 reference

Mechanisms of action of ribavirin in antiviral therapies

21 January 2018

1 reference

Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin

21 January 2018

1 reference

Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.

21 January 2018

1 reference

Terpenoids and flavonoids from Artemisia species

21 January 2018

1 reference